Psychiatry and Neurology, Neurology · Orlando, FL
NPI
1649710799
Since 2017
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
265 E Rollins St Ste 6
Orlando, FL, 32804
Phone (407) 303-6729
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
298 services
Medicare patients, 2024
138
Average age 71
Drug cost, 2024
$830K
470 prescriptions
Company payments, 2025
$2,816
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aqsa Ullah was code 99215 (office e&m - established), 54 times for 40 patients. In total Aqsa Ullah billed 298 services in 19 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 54 | 40 | $117.99 | $6,371 |
| 95886 Electrical Nerve Conductivity | Office | 52 | 52 | $69.37 | $3,607 |
| 99213 Office E&M - Established | Office | 32 | 26 | $64.54 | $2,065 |
| 99214 Office E&M - Established | Office | 29 | 27 | $91.86 | $2,664 |
| 95909 Electrical Nerve Conductivity | Office | 25 | 25 | $91.18 | $2,280 |
| 95910 Electrical Nerve Conductivity | Office | 25 | 25 | $110.54 | $2,764 |
| 95885 Electrical Nerve Conductivity | Office | 21 | 20 | $42.76 | $898 |
| 99204 Office E&M - New | Office | 13 | 13 | $77.19 | $1,003 |
| 99205 Office E&M - New | Office | 12 | 12 | $143.21 | $1,719 |
| 95912 Electrical Nerve Conductivity | Office | 11 | 11 | $178.97 | $1,969 |
By year: 2023 $31K for 280 services; 2024 $28K for 298 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aqsa Ullah prescribed most often to Medicare patients was Gabapentin, with 81 prescriptions and refills. In total Aqsa Ullah wrote 470 Medicare prescriptions that cost $830K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 81 | 141 | 26 | $1,719 |
| Pregabalin Generic | 77 | 91 | 19 | $3,950 |
| Prednisone Generic | 45 | 50 | Under 11 | $523 |
| Mycophenolate Mofetil Generic | 42 | 46 | Under 11 | $1,413 |
| Pyridostigmine Bromide Generic | 40 | 58 | Under 11 | $2,297 |
| Tizanidine Hcl Generic | 24 | 26 | Under 11 | $215 |
| Teglutik Riluzole | 14 | 14 | Under 11 | $53K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 14 | 14 | Under 11 | $367K |
| Sodium Chloride 0.9 % Sodium Chloride | 14 | 14 | Under 11 | $138 |
| Baclofen Generic | 13 | 15 | Under 11 | $220 |
| Glycopyrrolate Generic | 11 | 13 | Under 11 | $783 |
| Duloxetine Hcl Generic | 11 | 13 | Under 11 | $195 |
Brand drugs: 50 claims; generic drugs: 406 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aqsa Ullah $2,816 ($2,816 in general payments such as food, travel and fees) from 4 companies. The largest payer was Novartis Pharmaceuticals Corporation with $2,641.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.